Form D · Other Health Care
YorLabs, Inc.
Beaverton, OR · CIK 0001715843
Offering snapshot reported Oct 31, 2023 · SEC filing
- Reported sold
- $17.3M Offering amount: $20.1M
- Investors reported
- 34 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Oct 18, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 31, 2023 | Initial | $17,330,665 | No comparison | 34 | SEC filing |
| Nov 8, 2021 | Amendment | $12,531,570 | $6,500,002vs Nov 3, 2021 | 6 | SEC filing |
| Nov 3, 2021 | Initial | $6,031,568 | No comparison | 3 | SEC filing |
| Feb 11, 2021 | Amendment | $2,514,334 | $2,011,154vs Aug 13, 2020 | 53 | SEC filing |
| Aug 13, 2020 | Initial | $503,180 | No comparison | 23 | SEC filing |
| Oct 8, 2019 | Amendment | $3,349,969 | $1,689,969vs Aug 14, 2019 | 31 | SEC filing |
| Aug 14, 2019 | Initial | $1,660,000 | No comparison | 13 | SEC filing |
| Apr 3, 2019 | Amendment | $2,000,000 | $250,000vs Jan 2, 2019 | 46 | SEC filing |
| Jan 2, 2019 | Amendment | $1,750,000 | $567,500vs May 31, 2018 | 42 | SEC filing |
| May 31, 2018 | Amendment | $1,182,500 | $907,500vs Aug 31, 2017 | 32 | SEC filing |
| Aug 31, 2017 | Initial | $275,000 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-496120
Source: Form D, filed Oct 31, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Clark Brooks | Executive |
| Gregory D. Casciaro | Director |
| William Dai | Director |
| Nikki Troiano Gainey | Executive |
| Kirk Gerner | Director |
| Michael D. Goldberg | Director |
| Kelin Kuhn | Director |
| Timothy A. Marcotte | Executive |
| Glen Mclaughlin | Director |
| Glen W. Mc Laughlin | Director, Executive |
| Sunit Rikhi | Director |
| Anshumali Roy | Executive |
| William Starling | Director |
| William N. Starling Jr. | Director |
| William N Starling, Jr. | Director |
| William F Willis | Director, Executive |
| Bill Willis | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
9255 Sw Nimbus Ave
Beaverton, OR, 97008
Beaverton, OR, 97008